Search images on Google      Product Monograph

Active Ingredients:

• trastuzumab, 150 MG/VIAL

DIN: 02518244

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: AMGEN CANADA INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FD - (ATC, WHO)
• L01FD01 - TRASTUZUMAB (WHO)

 

External Links for Kanjinti:

Search on Google

• Kanjinti side effects
• Kanjinti dosage
• trastuzumab side effects
• trastuzumab dosage